Published in Immunobiology on June 04, 2010
Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol (2012) 1.11
Local response to microneedle-based influenza immunization in the skin. MBio (2012) 1.03
Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. J Exp Med (2015) 0.92
Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol (2015) 0.91
Dendritic cell-based vaccine efficacy: aiming for hot spots. Front Immunol (2015) 0.89
Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus. J Invest Dermatol (2013) 0.86
Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc Natl Acad Sci U S A (2012) 0.85
Macrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responses. J Immunol (2014) 0.85
CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates. Eur J Immunol (2012) 0.83
Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. PLoS One (2012) 0.83
Mechanisms by which chronic ethanol feeding impairs the migratory capacity of cutaneous dendritic cells. Alcohol Clin Exp Res (2013) 0.81
Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis. PLoS One (2015) 0.80
Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells. PLoS One (2015) 0.78
Calcitonin gene-related peptide: key regulator of cutaneous immunity. Acta Physiol (Oxf) (2015) 0.78
Cutaneous immunization: an evolving paradigm in influenza vaccines. Expert Opin Drug Deliv (2014) 0.77
Nerve-derived transmitters including peptides influence cutaneous immunology. Brain Behav Immun (2013) 0.77
An update on immunotherapy for food allergy. Curr Opin Allergy Clin Immunol (2010) 0.76
Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy. Oncotarget (2015) 0.75
Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity (2005) 6.48
Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol (2005) 5.97
Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol (2002) 4.63
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science (2007) 3.27
Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med (1993) 2.92
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest (2007) 2.46
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Dendritic cells in vivo: a key target for a new vaccine science. Immunity (2008) 2.31
Dendritic cells: understanding immunogenicity. Eur J Immunol (2007) 2.13
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol (2006) 2.09
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines (2008) 1.77
The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling. J Leukoc Biol (2006) 1.59
Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 1.46
Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A (2010) 1.45
Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol (2008) 1.31
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol Cell Biol (2010) 1.23
Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol (2002) 1.16
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol (2009) 1.10
Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol (2010) 1.06
Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol (2007) 1.05
Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Cancer Immunol Immunother (2008) 1.04
Isolation of skin dendritic cells from mouse and man. Methods Mol Biol (2010) 0.96
In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J Immunol (2001) 0.93
Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen. Eur J Immunol (2007) 0.88
CCR7 ligand-enhanced phagocytosis of various antigens in mature dendritic cells-time course and antigen distribution different from phagocytosis in immature dendritic cells. Microbiol Immunol (2005) 0.82
Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity (2005) 6.48
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood (2003) 3.40
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med (2002) 2.07
Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98
Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol (2003) 1.93
Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol (2005) 1.78
Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4. Biochem J (2013) 1.74
Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol (2002) 1.74
Langerhans cells - dendritic cells of the epidermis. APMIS (2003) 1.64
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. Eur J Immunol (2013) 1.63
Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol (2004) 1.60
The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling. J Leukoc Biol (2006) 1.59
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood (2013) 1.54
Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol (2002) 1.53
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol (2002) 1.49
Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol (2005) 1.45
A close-up view of migrating Langerhans cells in the skin. J Invest Dermatol (2002) 1.43
Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury. Kidney Int (2010) 1.41
Ontogeny of Langerin/CD207 expression in the epidermis of mice. J Invest Dermatol (2004) 1.41
Biopsychronology: live confocal imaging of biopsies to assess organ function. Transpl Int (2014) 1.38
Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol (2007) 1.38
Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes. Proc Natl Acad Sci U S A (2010) 1.33
Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol (2008) 1.31
Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol (2010) 1.31
Isolation of dendritic cells. Curr Protoc Immunol (2009) 1.30
Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol (2004) 1.29
Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol (2007) 1.25
FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci (2012) 1.25
The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol (2002) 1.25
Mitochondrial ROS production under cellular stress: comparison of different detection methods. Anal Bioanal Chem (2011) 1.24
Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med (2009) 1.24
Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation. Front Immunol (2012) 1.23
Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat Methods (2007) 1.21
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood (2004) 1.20
Epidermal Langerhans cells--changing views on their function in vivo. Immunol Lett (2006) 1.18
The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2. J Cell Biochem (2009) 1.15
A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol (2004) 1.13
Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol (2005) 1.12
The cell-type specificity of mitochondrial dynamics. Int J Biochem Cell Biol (2009) 1.11
Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. J Immunol (2009) 1.10
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol (2009) 1.10
Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology (2008) 1.10
Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol (2009) 1.09
A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol (2002) 1.08
Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: possible physiological role? Biochim Biophys Acta (2006) 1.08
The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer (2008) 1.08
Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood (2011) 1.06
Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol (2010) 1.06
Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci (2007) 1.05
Monocyte-derived dendritic cells release neopterin. J Leukoc Biol (2002) 1.04
Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Cancer Immunol Immunother (2008) 1.04
The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells. Biochem J (2009) 1.03
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood (2003) 1.03
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J Immunol (2011) 1.02
Effects of EpCAM overexpression on human breast cancer cell lines. BMC Cancer (2011) 1.00
Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate (2008) 0.99
NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge. J Immunol (2014) 0.99
Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol (2002) 0.97
Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle (2007) 0.96
Isolation of skin dendritic cells from mouse and man. Methods Mol Biol (2010) 0.96
Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions. Int Immunol (2008) 0.96
Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro. Prostate (2002) 0.95
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine. Immunol Cell Biol (2011) 0.94
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. J Immunol (2009) 0.93
CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. Blood (2009) 0.91
Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J Invest Dermatol (2003) 0.91
Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation. Endocrinology (2013) 0.91
Endothelial cells from cord blood CD133+CD34+ progenitors share phenotypic, functional and gene expression profile similarities with lymphatics. J Cell Mol Med (2009) 0.91
Survival signaling by C-RAF: mitochondrial reactive oxygen species and Ca2+ are critical targets. Mol Cell Biol (2008) 0.90
ORF virus infection in a hunter in Western Austria, presumably transmitted by game. Acta Derm Venereol (2014) 0.89
Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol (2009) 0.88